Merger Rhein Biotech N.V. with Crucell subsidiary to be effected on December 27th 2006
Advertisement
Rhein Biotech N.V has proposed to legally merge with a (directly and indirectly) wholly owned subsidiary of Crucell N.V. Shareholders of Rhein Biotech N.V. will in exchange for each share in Rhein Biotech N.V. receive 1.158 shares in Crucell N.V. A general meeting of shareholders of Rhein Biotech N.V. will be held on December 22, 2006 in order to resolve to effect the legal merger.
After finalizing certain legal formalities the notarial deed of merger will be executed on December 27, resulting in Rhein Biotech N.V. ceasing to exist one day later and therefore its shares being delisted from the Frankfurt stock exchange.